[ET Net News Agency, 2 February 2023] HANSOH PHARMA (03692) rose 3.19% to HK$16.82,
breaking above the 20-D SMA of HK$16.8.
It hits an intra-day high of HK$16.82, and an intra-day low of HK$16.12. The total
shares traded was 440,200, with a value of HK$7.27m. The active buy/sell ratio is 58:42,
with net buying turnover of HK$1.1m. UBS SEC accounts for greatest net responsive buying
turnover of HK$341,071, with volume weighted average price of HK$16.476. GOLDMAN SACHS
(ASIA) SEC accounts for greatest net responsive selling turnover of HK$812,690, with
volume weighted average price of HK$16.451. The stock has risen a combined 4.86% over the
past 2 consecutive trading days.
The Hang Seng Index now rose 130 points, or 0.59% to 22,202.

Basic Information
=================

----------------------------------
Nominal 16.820 % Chg +3.19%
High 16.820 Low 16.120
Shares Tr 440,200 Turnover 7.27m
10-D SMA 16.692 %H.V 47.425
20-D SMA 16.800 VWAP 16.510
50-D SMA 15.468 RSI14 56.031
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 58:42, with net buying
turnover of HK$1.1m, rising a combined 4.86% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HANSOH PHARMA (03692) 16.82 +3.19
ALI HEALTH (00241) 7.09 +0.57
TRAD CHI MED (00570) 4.06 +4.10
SINO BIOPHARM (01177) 4.72 +2.61
INNOVENT BIO (01801) 46.90 +3.19
EVEREST MED-B (01952) 28.60 +11.72
WUXI BIO (02269) 69.40 +3.50
NH HEALTH-B (06606) 35.25 +6.82
AKESO-B (09926) 50.20 +2.45
ALPHAMAB-B (09966) 16.86 +13.61
---------------------------------------------
(ed)